The authors have declared that no competing interests exist.
‡ JJ, TLH and ANS also contributed equally to this work.
Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy, with an incidence of 1-2/100,000 per year. Its severity is variable, ranging from very mild cases with brief weakness to severe paralysis, leading to inability to breathe independently, or even death. Currently there is limited evidence exploring the experiences of GBS patients. The aim of this study was to review patients’ experiences and perceptions of GBS and its variants at diagnosis, discharge and during recovery, by conducting a systematic review and thematic meta-synthesis of qualitative studies of patients’ experiences of GBS (and its variants).
We searched twelve electronic databases, supplemented with internet searches and forward and backward citation tracking from the included studies and review articles. Data were synthesised thematically following the Thomas and Harden approach. The CASP Qualitative Checklist was used to assess the quality of the included studies of this review.
Our search strategy identified a total of 5,282 citations and after removing duplicates and excluding citations based on title and abstract, and full-text screening, five studies were included in the review and meta-synthesis; all included studies were considered of acceptable quality. Through constant discussions and an iterative approach, we developed six analytical themes following a patient’s journey from suspecting that they had a health problem, through to being hospitalised, experiencing ongoing difficulties, slowly recovering from GBS, adjusting to their new circumstances, and re-evaluating their lives.
Despite the variety of experiences, it was evident from all included studies that being diagnosed with and surviving GBS was a life-changing experience for all participants.
Protocol was registered (
Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy, with an incidence of 1-2/100,000 per year [
Currently there is limited evidence exploring the experiences of individuals who have had GBS. Previous research highlights the significant impact of GBS on individuals and their families. One study [
We used two theoretical models to facilitate data gathering, analysis and interpretation of the experiences of patients with GBS, the Illness Trajectory Framework (ITF) [
According to the ITF [
The [
The findings of this review will provide insights into the patient journey, which could be useful in informing patient care and support services.
Given the severity of GBS and how variable its onset and course are, it is imperative to explore in depth the patients’ experiences of GBS at the time of diagnosis, during their hospitalisation, in the period post-discharge from hospital and on their return to the community, in order to better understand this patient group’s health and social care needs, as well as explore any potential facilitators and barriers to recovery and return to function. Furthermore, based on our preliminary searches, to date no systematic reviews of qualitative studies exploring patients’ experiences of GBS have been published.
The aim of this study was to review patients’ experiences and perceptions of GBS and its variants at diagnosis, discharge and during recovery, by conducting a systematic review and thematic meta-synthesis of qualitative studies of patients’ experiences of GBS (and its variants).
We followed ENTREQ guidelines for enhancing transparency in reporting the synthesis of qualitative research [
Our review question was: What are patients’ experiences and perceptions of GBS and chronic inflammatory demyelinating polyneuropathy (CIDP) and its care at diagnosis, discharge and during recovery?
Studies were eligible for inclusion if they had a qualitative research design (e.g. interviews, focus groups, ethnography) and reported on patients’ lived experience of GBS and CIDP. Healthcare services (including the treatment, care and support they provide) have changed considerably in the last 20 years and consequently so has patient experience of care. To ensure that the reviewed patient experiences are relevant to the present day and can inform improvements in current practice, only studies published between January 2000 and May 2020 were eligible for inclusion. In addition, only peer reviewed studies, written in English were considered for eligibility.
Qualitative studies published outside these dates or in other languages were excluded. Quantitative studies were also not eligible for inclusion, since we were interested in patients’ lived experience of GBS and CIDP and we wanted to include in depth accounts of their experiences (preferably expressed in their own words, i.e. by using quotes).
Electronic database searches were performed in the Cochrane Library, Joanna Briggs Institute Evidence-Based Practice Database, PROSPERO, MEDLINE, Academic Search Complete, AMED, CINAHL, Humanities International Index, PsycARTICLES, PsycINFO, EMBASE, and PubMed. All databases searches were supplemented with internet searches (i.e. Google Scholar), and forward and backward citation tracking from the included studies and review articles.
The search strategy used in all the above databases included a combination of two sets of keywords and related terms: 1) Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), acute inflammatory demyelinating polyneuropathy (AIDP); combined with 2) qualitative research, interview, focus group, experiences, perceptions, attitudes, and views. The search terms were entered using Boolean operators and truncation, wherever deemed necessary. Medical Subject Headings (MeSH) were also employed in forming the search strategy. For the full search strategy used for the Medline database, see
Search ID | Search terms |
---|---|
S1. | (MH "Guillain-Barre Syndrome") OR (MH "Miller Fisher Syndrome") OR (MH "Posterior Cervical Sympathetic Syndrome") OR "Guillain–barré syndrome" |
S2. | Guillain-Barre syndrome or gbs or Guillain-Barré |
S3. | (MH "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating") OR (MH "Guillain-Barre Syndrome") OR (MH "Polyneuropathies") OR (MH "Demyelinating Diseases") OR "chronic inflammatory demyelinating polyneuropathy (cidp)" |
S4. | S1 OR S2 OR S3 |
S5. | (MH "Qualitative Research") |
S6. | interview* or focus group* |
S7. | experience* or perception* or attitude* or view* or feeling* or opinion* or reflection* or belief* |
S8. | acute inflammatory demyelinating polyneuropathy OR aidp |
S9. | S1 OR S2 OR S3 OR S8 |
S10. | S5 OR S6 OR S7 |
S11. | S9 AND S10 |
All references were reviewed and screened by three reviewers (FC, DL, JA) independently. Titles and abstracts were initially screened for relevance and final eligibility was assessed through full-text screening against the inclusion criteria, using a pre-designed study selection form. Any disagreement between the reviewers over the eligibility of references was resolved through discussion between the reviewers, and in consultation with a fourth reviewer (ANS) when necessary.
A standardised, pre-piloted form was used to extract data from the included studies for assessment of quality and data synthesis. Extracted information included: study details (title, authors, date, country), methods (aims, objectives, research questions, study design, setting, data collection methods), participant characteristics (demographics, inclusion/exclusion criteria, method of recruitment, sample selection, sample size), and study findings (main and secondary outcomes, data analysis, conclusions). One reviewer extracted data and a second reviewer checked the data extractions for accuracy. Any discrepancies were resolved through discussion and missing data were requested from study authors.
Data were entered into NVivo 11 qualitative data analysis software to facilitate analysis. We used thematic synthesis to synthesise the data, following the Thomas and Harden [
We followed an inductive approach to analyse and synthesise the data, rather than imposing the illness trajectory framework (ITF) or Taylor’s theory of cognitive adaptation onto our results. Instead, we used both these models to interpret the results and describe the patient journey from experiencing the first GBS symptoms to hospital discharge and recovery (see
The Critical Appraisal Skills Programme (CASP) Qualitative Checklist [
Three reviewers (JA, FC, DL) independently assessed the quality of the included studies. Discrepancies were resolved by discussion and consensus, and in consultation with a fourth reviewer when needed (ANS).
Reflexivity enables authors to recognise the assumptions and preconceptions they bring into the research and may influence the research process, while allowing the reader to understand the dynamics between the researcher and the researched. This review was commissioned and developed in discussion with the chief executive and chair of the board of trustees of the charity ‘Guillain-Barré and associated Inflammatory Neuropathies’ (GAIN). GAIN was the main funder of the study and helped develop the review’s main objectives: exploring GBS patients’ experience of care, particularly focussing on the period following discharge from hospital and return to the community.
The reviewers (except for ANS and JA) had no prior knowledge of or experience with GBS. DL, a psychologist by background and a researcher in health services, has experience in quantitative systematic reviews and in the analysis of qualitative data. FC is a research fellow whose research predominantly focuses on non-pharmacological interventions for the prevention and management of chronic conditions. She has experience conducting systematic reviews of both quantitative and qualitative studies. JA has a background in clinical nursing and public health with expertise in qualitative and quantitative research methods, and systematic reviews. As a nurse, JA has general clinical knowledge of GBS. JJ is a community researcher with interest in the patient and service user experience, as well as extensive experience of qualitative and engaged research within the public sector, community and voluntary groups. TLH is a psychologist with interest in cognitive deficits in patients with neurodegenerative disorders, with experience of analysis of quantitative data and knowledge of the neurology of cognition and perception. ANS is a clinical academic general practitioner (GP) by background with expertise in social science methods, including systematic reviews, qualitative meta-syntheses and qualitative studies more generally. He has general clinical expertise and insight into GBS but is not an expert on the condition itself.
Familiarisation with the papers included in this review, together with being aware of the existence of GBS-dedicated charities, may have influenced the authors’ suggestions regarding potential sources of support for patients in the future; such support may be available from multiple sources, and our view may have been influenced by the funding for this study.
The search strategy identified a total of 5,282 citations. After removing duplicates and excluding citations based on title and abstract, 63 articles remained for full-text screening. A further 58 articles were excluded based on inclusion/exclusion criteria (main reasons for exclusion: paper not written in English, and/or a quantitative design), leaving five studies to be included in the review and meta-synthesis.
The five included studies (
Study | Study aims | Sample | Method of data collection | Method of data analysis |
---|---|---|---|---|
Cooke & Orb, 2003; Australia | To “examine the perspectives of patients with Guillain-Barré syndrome during their recovery phase” | Purposive sampling of 5 participants (3 male, 2 female) admitted to the hospital with a diagnosis of GBS; discharged from hospital in the last 2 years | Semi-structured individual interviews with open-ended questions | Constant comparative method |
Ages: 28–67 years | ||||
Forsberg et al., 2008; Sweden | To “describe experiences of falling ill with GBS, with the focus on the onset of disease, the diagnosis and the illness progress during hospital care” | The study population (35 participants: 22 male, 13 female) was identified in a previous multicentre study, including eight hospitals. Participants were approached 2 years after illness onset. | Individual interviews | Content analysis |
Ages: 20–78 years | ||||
Forsberg et al., 2015; Sweden | To “describe experiences of disability in everyday life and managing the recovery process two years after falling ill with Guillain-Barré syndrome” | The study population (35 participants: 22 male, 13 female) was identified from a previous longitudinal study. Participants were approached 2 years after illness onset. | Semi-structured individual interviews | Content analysis |
Ages: 22–80 years | ||||
To “gain a richer understanding of the patient’s recalled experience of an acute episode of moderate to severe Guillain-Barre’ syndrome” | Individuals, from eight different states, with a prior self-identified diagnosis of moderate to severe GBS. The sample (recruited through different strategies) included 10 females and 4 males. | Semi-structured individual interviews | Content analysis | |
Ages: 19–79 years | ||||
Royal et al., 2009; UK | To “investigate in greater detail participants’ motivations for returning to work after GBS, the subjective impact of GBS on their ability to return to work, and how they managed their return to work.” | Five GBS patients (4 male, 1 female) who had returned or attempted to return to work following their illness. Participants were selected from a database of patients, who had been admitted to a specialist rehabilitation unit between 2000 and 2006. Participants were interviewed between 1 and 5 years after their admission to hospital with GBS. | Semi-structured individual interviews | Interpretative phenomenological analysis |
Ages of onset of GBS: 25–63 years |
* PhD thesis.
Study | CASP01 | CASP02 | CASP03 | CASP04 | CASP05 | CASP06 | CASP07 | CASP08 | CASP09 | CASP010 |
---|---|---|---|---|---|---|---|---|---|---|
Cooke & Orb, 2003 | ||||||||||
Forsberg et al., 2008 | ||||||||||
Forsberg et al., 2015 | ||||||||||
Hooks, 2015 | ||||||||||
Royal et al., 2009 |
After initial coding and development of descriptive themes, we developed six analytical themes (
Analytical theme | Descriptive themes | Some supporting quotations |
---|---|---|
Theme 1: From uncertainty to hope | Initial strange sensations | “Most participants described the initial symptoms that were manifested as strange or odd sensations or peculiar feelings” [ |
Rationalising symptoms & misattributing diagnosis | “A few persons tried to ignore the strangeness of their bodies, but others came up with explanations such as being tired or overworked. [….] Some also described a fear of having a better-known disease such as cancer or multiple sclerosis” [ |
|
“This participant went to the physician’s office for care. The physician’s office called for emergency support and transport because they felt this participant was having a stroke” [ |
||
Participants’ eagerness to find out what’s happening to them | “…when I got to the hospital, [I felt] more curious. What’s going on? What’s causing this?” [ |
|
Uncertainty | “The uncertainty was overwhelming for many and affected their whole lives” [ |
|
Healthcare professionals’ lack of knowledge and experience with GBS | “I just wish that, um, that the people who were treating me had known more about it, You know, it’s not comforting when, you know, a nurse walks in and said: I didn’t know anything about it, so I had to Google it. You know, I didn’t find that comforting. And there were–there was more than one person that–that said they had never really heard of it” [ |
|
Need for information about GBS | “Many participants expressed the desire to have more information about their illness. In addition, participants commented on the value of this knowledge and the impact that it had in terms of their future outlook” [ |
|
Friends and family the main source of information about GBS | “My daughters–my three daughters flew in, and they were there with my wife. And, uh, they are all very techy, so they were looking up everything they could find on the Internet about it at the time” [ |
|
“…another participant discussed the value of the resources provided by the GBS/CIDP Foundation International” [ |
||
Prospect of a positive prognosis | “The concern of having a very serious disease and the fact of a prolonged recovery was becoming a realization, while others in the same situation still continued to rely heavily on the prospect of a positive prognosis” [ |
|
Hope of recovery | “After being confronted with physical dependency and then encountering helplessness, the participants were hopeful that recovery was near” [ |
|
Theme 2: Feeling lost in a changing life | Experience of physical symptoms | “In the morning I felt numbness in one hand, and in the afternoon I could not swallow. By midnight, I could not breathe and was taken to intensive care for ventilator support” [ |
Loss of identity | “Some talked about being handicapped and losing their identity as an independent person” [ |
|
Dependency, vulnerability and feelings of helplessness | “Their bodily limitations disappointed them and made them feel helpless, as they were dependent on assistive devices or were not able to participate in activities in the same way as before” [ |
|
Feelings of shame and embarrassment | “…when I could still walk they bathed me in the shower, which I thought was horribly traumatizing. Because, you know, I was 25. And being bathed by someone was, like, extremely embarrassing. So that was, I think, the first day of, like, my traumatic–when I say my traumatic experience. When I started crying like every day. That was the first day…maybe a day or two later is when I couldn’t walk. So then they came in and gave me a sponge bath. So I ranked that as even worse. It’s just very–It felt very demeaning because, you know, I was still young and somebody here bathing me on my bed. I thought it was terrible” [ |
|
Psychological responses to GBS | “…there were so many. Frustration that I couldn’t figure out what was wrong with me. Guilt because I was taking so many drugs. There was…a not knowing what was wrong with me was, um, just heart-breaking. A frustration when I fell at work, I laid in the doorway of my job, and I just cried”.” This variety of emotions is mirrored in another participant’s quote as well: “…Elation, I guess. When you’re finally going to get out of the hospital…Anger over the care at rehab. And anger with the doctors not being able to listen…doctors are amazingly poor listeners. And gratitude. I mean, geez. I don’t know. You know, it’s one of those times where thanks is not adequate, but it’s all you got” [ |
|
Effects of GBS on family life | “I was worried about my husband too, I guess. That was a part of it. All my family–I’m from a big family, but everybody lives someplace else…But as I got better, I worried about him and, you know, where he was getting support” [ |
|
“This was the first Christmas in 38 years she ever prepared a Christmas ham. All these years it was I who’d done it–done all that kind of thing” [ |
||
Difficulties with re-assuming social lives | “The social relationships and friendships you’ve had before get curtailed somehow. I just don’t get together with a lot of my friends–friends I met through memberships in clubs and recreational groups” [ |
|
Experiencing work-related difficulties | “So some days when I phoned in and said I’m not coming in today it wasn’t necessarily because my legs weren’t working properly or I didn’t feel strong enough physically, it was mentally I didn’t feel strong” [ |
|
Theme 3: Fractured care | Lack of continuity of care | “Lack of continuity was also described, for example having to wait a long time for referrals that evidently delayed the start of rehabilitation” [ |
Lack of person-centred care at hospital | “There were some [staff] during the day, and I knew who to ask for to help me do that during the day. But in the evening, they basically told me they were not going to help me. That I weighed too much” [ |
|
“I will take the bedside commode, but I will not do the bedpan. So that’s really when they started telling me they were not going to move me” [ |
||
Feeling not listened to by healthcare staff | “…my worst experience about this was having the alarm on my bed. And you know hearing the voice that come over the intercom saying: Do not get out of bed! And to be yelled at. I mean that’s the only way I can put it. You know they weren’t really mean, but you know, being told, ‘Don’t get out of bed’, you know, all of the time just kind of ticked me off a little” [ |
|
“And anger with the doctors not being able to listen…doctors are amazingly poor listeners” [ |
||
Communication issues with healthcare staff | “I mean, the doctors–honestly, I understand that, you know, you’re doctors. You’re busy in a big hospital. But they don’t have time to sit down with you and explain exactly everything that is going on. It’s just: This is what you have. This is sort of how it works: And here’s your prognosis’” [ |
|
Feeling that needs are not being met by healthcare staff | “I remember one day they had me riding on a bicycle… [and] a physical therapists [should] not push, push, pushing somebody to the point of exhaustion. That’s the only mistake–I wouldn’t even say mistake. But you know what I mean. It’s the only big thing…I just think it’s set up for a different kind of rehab than what I needed” [ |
|
“…the mental process of going through this illness was never addressed, really, except by me” [ |
||
Lack of publicity about GBS | “A silly example, if somebody is pregnant, when they come back you know basically what to expect…and how to treat that person. . .but you can’t blame the management, you can’t blame work colleagues because [people] don’t know…” [ |
|
Theme 4: Positivity towards recovery | Positive feelings towards healthcare received (e.g. physical care needs were met; kind staff; medical staff were conscientious) |
“…my hunch is that they probably didn’t have a lot of experience with it….they might not have been prepared…but as far as dealing with my disabilities, they were great. Even if they didn’t understand what caused it themselves. But, you know, to help me do the necessities” [ |
“I still remember, when I am getting myself dressed, there was an aid…and she was the one that would help me get dressed. So she, you know would, I’d want to put my undies on and pull them up, and I’d want to put my pants on and pull them up. And she said…we’re going to do this a better way. We’re going to put those undies on and the pants on, then we’re going to pull up one time. And I thought: Great idea!” [ |
||
Getting support from family and friends (including colleagues) | “I can turn myself but it’s a challenge. But my wife helps me” [ |
|
“That’s the kind of thing I think is almost the hardest: when people say ‘Well obviously you just have to try harder’” [ |
||
“… I think it is important to get back on board, need the company and intellectual stimulation. Brain was starting to numb out a bit, definitely, and you know it’s quite a close knit company that I work at. I consider them all to be friends as well, so there is a support structure there” [ |
||
Importance of peer support | “There were two people who had GBS…One was this man. He had GBS and now he was working and he was back at work and we related and talked. And the other one was Miss L…She still calls me every now and then. Just came by to talk and visit with me. And that was very nice, and that was–and they told me a lot about…recovery, I guess. Recovery was possible, you know. That was very helpful…And it was sort of an affirmation that things should get better” [ |
|
“If you ever have anybody in here, in this condition…I’d be happy to come over, and I’ll shoot the breeze for a little while. And tell them, you know, you can get better, you know? And I think if I would have heard something like that from somebody who had been through it, rather than a caregiver giving it to me, I think it would have had a lot more impact on how I would have perceived everything. I really do. The issue [with hearing it from a caregiver] was probably a lack of credibility on my part” [ |
||
Maintaining a positive attitude | “They told me that the course is positive for nine out of ten patients, so most recover completely. I got the feeling that now it is just to be strong and then everything will be fine” [ |
|
“Your life isn’t over. And I know it seems like it but it’s not. It’s going to get better but your attitude is everything. Your attitude will make or break this thing for you” [ |
||
Theme 5: Adjustment | Experiences of recovery varied | “There was a broad variation in the participants’ experiences of the recovery process and adjusting to their new situation after falling ill with Guillain-Barré syndrome. Some said that they did not have any residual symptoms, and had regained full bodily strength and health by the time of the interview. They had experienced a recovery period lasting a couple of months, and gradually all their symptoms had resolved.” [ |
Symptom management | ‘If you’ve asked for something, you get help. But as for the actual problem…you end up having to pretend you’re some kind of expert on your own illness after a while, in order to really get the help you need.’” [ |
|
“Strategies to lessen the impact of leg weakness included deliberately walking more slowly in order to save energy. ‘If I speed up, I can’t walk very far, but if I walk slowly, I can almost walk any distance’” [ |
||
Need for control and independence | “And then when I started to exercise and discovered that I could stand up, everything went very fast” [ |
|
Achieving milestones | “A desire to move on and get this thing behind me. One of the best ways of doing that is going back to work, definitely” [ |
|
“Well, little by little, you know things got better. I mean, I can remember being so excited at home when I had to–I could actually get myself a cup of coffee and walk across the room without a walker…with a cane…and sit down in a chair, and do that all by myself. I thought that was just …a major feat” [ |
||
Acceptance of their situation | “The descriptions of the recovery process showed that the participants were in different phases of acceptance and coping, independently of their current health status. Some neglected the influence of the consequences of the disease on their life situation. Others said that they had reappraised their new situation and found ways to manage their restrictions and limitations in activities.” [ |
|
“It may not be the light that you’re hoping to see, but at least, you know there’s light” [ |
||
Remaining positive, despite persisting symptoms | “Much stiffer…you feel so old in the morning when you try to put your socks on. You have to put your foot on your knee…but it’s not like I’m suffering from that” [ |
|
“One participant who had to use a wheelchair said: ‘I’m so relieved I didn’t lose my speech or my mind ‘” [ |
||
Theme 6: Towards a new self | Desire to go back to ‘normal’ pre-GBS selves | “I have one goal, and that is to get well. And I mustn’t let myself think it’s hard. As soon as I’m able to walk, we can get going on all the other stuff” [ |
Hiding GBS | “… I didn’t want anybody to, if you like, know the truth about what I was, how I was feeling at the time” [ |
|
Fear of stigma | “… I must admit I didn’t tell them I couldn’t feel my feet.” [ |
|
“People look at you and think what’s the matter with him? No honestly, work is okay now [but], when I first went back I did have to concentrate very, very hard because I didn’t want to draw attention to myself” [ |
||
Others' perceptions of GBS | “To start with I was really self-conscious and I still I am a little, but not as much as I was. Colleagues actually seeing my lips don’t move in the normal way and I know that sometimes I would say a word and I was quite sure that they knew what the word was but they got confused… they wonder what’s going on, but no-one actually normally says anything” [ |
|
Returning to work seen as going back to ‘normal’ self | “That [work] was good for me because I was normal again, I thought I was the same as I was before I had the Guillain- Barré, I was the same person again. Obviously I wasn’t but I thought I was, and that was good enough for me” [ |
|
“I want it all to be forgotten, as if it never happened… so I’d rather be back, I’m quite happy to get back into normal life” [ |
||
Motivations for going back to work | “.... I ended up with about thirty pounds a week benefit and then I realised I had to try and get back to work as soon as possible” [ |
|
“The job, it was probably therapeutic for me because I didn’t use to go to the depot in my car… it gave me a mile walk, about three quarters of an hour walk down to the depot which I thought was therapeutic… it was therapy for me but I was getting paid for [it]” [ |
||
Facilitators to going back to work | “I was able to drift off into the meeting room and have half an hour’s kip on the sofa, which everyone was totally okay with… if you do that during the middle of your working day, it completely recharges your batteries” [ |
|
“Friday is like a buffer day… I think that’s quite important and basically you know, I can have a good sleep, have a breather and recharge my batteries and then the weekend is for the family and Monday is a buffer day similarly at the other end. . .” [ |
||
“…so what I was able to do was actually go out and employ someone who was much more specific to the needs that I now have” [ |
||
Barriers to going back to work | “You can’t do that [rest] at work, when you get to work if you’ve had a bad journey, you know, you can’t have a lie down unfortunately” [ |
|
“Although most workplaces offered some flexibility at first, this was usually only possible on a short-term basis. […] But only Andrew and Edward had sufficiently senior positions to resist taking all aspects of their job back, ‘… You’ve got to be careful not to take all that… back on. . .’ (Andrew), ‘… I’ve said no’ (Edward)” [ |
||
Re-evaluating life | “The participants also described positive aspects, in that the onset of disease and the recovery process had made them reflect on their life situation, and some had made significant changes in their work situation or choice of leisure activities” [ |
Participants tried to ignore initial strange sensations due to GBS [
Uncertainty for participants often became overwhelming, making them eager to find out what was happening to them [
Although some participants were sad and disappointed about the long recovery ahead of them, many relied on the prospect of a positive prognosis and hoped for a full recovery [
Having GBS affected every aspect of participants’ daily lives [
As a result, some participants felt they had lost their identity as an independent person [
Having GBS influenced participants’ family lives. Participants were worried about their family’s wellbeing, while they were hospitalised [
Participants were generally dissatisfied with healthcare service support which they considered a key barrier preventing recovery from GBS. Participants felt that there was lack of personalised and person-centred care, lack of continuity of care, lengthy waits for referrals, and staff shortages, which made it harder for participants to receive the care they needed [
Participants also felt not listened to by healthcare staff and experienced poor communication from healthcare professionals [
Participants also identified a want of publicity about GBS as a main factor contributing to the lack of support they received, especially when returning to work, as the public did not have any insight into the long term effects of GBS or what to expect when interacting with the participants [
In contrast, participants variously expressed an overall satisfaction with the care they received from community and hospital healthcare, commending kind staff attending to their physical care needs with efficient treatments [
Another facilitator to recovery from GBS was the invaluable support from their family and friends, including both practical (e.g. help with the home and transportation) and psychosocial support (e.g. gathering information about GBS or being emotionally supportive) [
Support from colleagues was also viewed very highly by participants and motivated them to go back to work, as they often considered their colleagues as friends as well [
Peer support was also viewed as really important by participants [
Finally, participants’ positive attitude was a major facilitator to their recovery from GBS and helped them realise that life wasn’t over and that things would eventually improve [
There was wide variation in participants’ experiences of recovery, coping with and adjusting to their new situation. For some recovery lasted months and was full, whereas others were still experiencing residual symptoms years later [
Setting and achieving ‘milestones’ was another major motivating factor, with different participants viewing different points in their patient journey as milestones [
Adjusting to their new situation required participants to first accept their new circumstances [
A recurring theme was participants’ attempts and eagerness to return to their ‘normal’ pre-GBS selves and everyday lives. Often, going back to an acceptably ‘normal’ identity and avoiding the potential stigma of GBS required rejection of overt disability, with participants trying to conceal their impairments or avoid discussing them [
Participants were sensitive to other’s reactions at work, especially when colleagues’ behaviour changed towards them [
Despite these concerns, returning to work was seen positively, as going back to their ‘normal’ selves again, and offered a distraction from the participants’ residual difficulties [
The main factor facilitating participants’ return to work was workplace adaptations. For some, such accommodations included having the right workplace resources or limiting their responsibilities, especially if they considered stress as a factor in their illness, by being able to change or reduce working hours [
Some workplaces did not have any appropriate resources, such as a quiet place for resting, and when participants went back to work, they were offered only short term flexibility, being expected to soon fully return to their previous responsibilities [
Overall, it was evident from all five studies that living with GBS had been a life-changing experience [
This systematic review and thematic meta-synthesis explored patients’ experiences and perceptions of GBS at diagnosis, discharge and during recovery. Participants’ experiences of recovery varied significantly, many still experiencing residual (physical, psychological and social) difficulties even years after their discharge from hospital. These results are closely aligned with concepts suggested by both the Illness Trajectory Framework (ITF), proposed by Corbin & Strauss [
Our results showed that the
Although the
There are many factors that affect how an illness progresses and how recovery can be affected positively or negatively. Our results, for example, showed that patients struggled with the lack of knowledge among healthcare professionals and the lack of information about GBS they received. Similar results were also found in past studies [
Another facilitator to recovery was support from family and friends, also found in past studies [
More importantly, our meta-synthesis found novel factors that might positively affect recovery. Maintaining a positive attitude, for example, was the first step towards recovery from GBS and helped participants take control of their situation, try to manage their symptoms themselves and regain their independence; a finding in accordance with Taylor’s theory [
Achieving major milestones also helped participants adjust to and
For the majority of GBS cases there is no real
This review has brought together papers discussing different aspects of people’s experience (such as during an acute episode [
The study followed a rigorous pre-specified protocol (registered with PROSPERO), which ensured that the review process was transparent and replicable. We conducted a comprehensive search for published and unpublished work, through twelve electronic databases, internet searches and scanning of bibliographies. The five included studies were of acceptable quality and included rich data.
A potential limitation of this review was including exclusively English-language papers, as important evidence may have been excluded due to language restrictions. However, methods for translating concepts across languages, in addition to the initial challenge of translating them across studies, have not been sufficiently developed [
Exploring this literature has enabled us to identify how patients may need extra support to cope better with their recovery and also identify ways that healthcare professionals and services can help facilitate further such a recovery.
One of the most important areas that needs to be addressed is the lack of knowledge about GBS among many healthcare professionals, including the lack of provision of information to patients about their condition and prognosis. Offering additional training on GBS for healthcare professionals might be an appropriate first step towards improving their knowledge, while providing educational resources and information for the public could be another helpful action. Informing patients of available support services (such as financial aid, health and social care services, as well as relevant charities) would further ensure that people receive appropriate and personalised care, facilitate their transition from hospitalisation to returning to their everyday lives and, potentially, aid recovery.
Patients’ psychological needs were often not met by healthcare services, while maintaining a positive attitude was identified as essential for participants to be able to cope with and successfully recover from GBS. It would be useful, therefore, to add psychological therapies to patients’ treatment regimens, if needed and wanted by patients.
We found that participants also viewed peer support as important in their road to recovery. Peer support could help address both areas discussed earlier, regarding lack of information and emotional support offered to patients with GBS. This could also be an area for future research, exploring how peer support should be provided and that it was clinically beneficial before planning for peer support to be widely available to patients with GBS, potentially through hospitals or GBS charities.
Finally, patients often reported requiring extra support to enable them going back to work. This, according to our results, would include increased awareness of GBS and its sequelae for employers, which in turn would increase understanding of the condition by employers and, therefore, making them more inclined to provide adaptations at work for patients wanting to return to their jobs (e.g. flexible working hours/days, areas for rest, etc.).
This systematic meta-synthesis explored patients’ experiences of GBS at diagnosis, discharge and during recovery. One factor that positively influenced management and eventually outcomes was having a positive attitude and thinking towards recovery. Other key factors influencing management were receiving adequate information about GBS, having support from valued others (such as family members, friends or peer support), and receiving satisfactory care from healthcare services (especially nursing care). Despite the variety of experiences, it was evident from all included studies that being diagnosed with and surviving GBS was a life-changing experience for all participants.
(DOCX)
(PDF)
We would like to thank the members of the Community and Health Research Unit (CaHRU) study review group (University of Lincoln) for their valuable comments on a draft of this paper.
PONE-D-19-33700
Patients’ experiences and perceptions of Guillain-Barré syndrome: a systematic review and meta-synthesis of qualitative research
PLOS ONE
Dear Dr Aloysius Niroshan Siriwardena
Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
We would appreciate receiving your revised manuscript by 30 days. When you are ready to submit your revision, log on to
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.
To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see:
Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.
We look forward to receiving your revised manuscript.
Kind regards,
Federico Bilotta
Academic Editor
PLOS ONE
Journal requirements:
When submitting your revision, we need you to address these additional requirements.
1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at
2. We note that your search concludes in November 2018.
It is not clear why studies published in the last 12 months were not included for consideration.
Please provide a rationale for the search window, or update the search to include studies from the last 12 months.
Additional Editor Comments:
PONE-D-19-33700
In this SR and meta-synthesis, the Authors have discussed the patients’ experiences and perceptions of Guillain-Barré syndrome (GBS) and its variants at diagnosis, discharge and during recovery, by conducting a systematic review and thematic meta-synthesis of qualitative studies of patients’ experiences of GBS (and its variants).
The Authors searched 12 electronic databases, supplemented with internet searches and forward and backward citation tracking from the included studies and review articles. Data were synthesised thematically following the Thomas and Harden approach.
The Authors identified a total of 4,204 citations and after removing duplicates and excluding citations based on title and abstract, and full-text screening, five studies were included in the review and meta-synthesis; all included studies were considered of acceptable quality. Through constant discussions and an iterative approach, we developed six analytical themes following a patients journey from suspecting that they had a health problem, through to being hospitalised, experiencing ongoing difficulties, slowly recovering from GBS, adjusting to their new circumstances, and re-evaluating their lives.
The Authors concluded that, that being diagnosed with and surviving GBS was a life-changing experience for all participants.
Editor’s comments: this SR is interesting, but provide some methodological limitations.
The main outcome of the study should be summarize as last sentence of the introduction.
The subchapter “Theoretical perspective” should be shortened by 50%, the introduction section is lengthily and not focused on the primary end point.
The Table should be reported at the end of the manuscript, and cited in the text.
The Result section is composed by 20 pages. The Section is too lengthily. Please report only the results statistically significant in the text, the all results should be reported only in the Table.
The first sentence of the Discussion section should summarize the main results of the study.
Also the Discussion section is long and lengthily. Please shortened by 30 to 40% and focused it on the primary end points of the study.
Reviewer 1: I've read with great interested this work by Siriwardena et al. dedicated to patients’ perceptions of Guillain-Barré syndrome. Undoubtedly, the data presented in this article are of great interest for specialists working with such patients. However, in my opinion, this article is extremely overloaded with data, which makes it really huge and looks like small book or thesis but not journal article. For instance, discussion section essentially repeats, in an abbreviated version, most of the theses set out in the results.
The design of the study is not completely looks optimal to me, because it is not clear what new information this meta-synthesis provides us, compared to the five qualitative studies that were included in the analysis. What has changed in our understanding of the problem after this work? It is also not entirely clear why the authors excluded quantitative works, because, at least, discussion sections of them could also contain some useful information.
In my opinion, the work needs a serious revision aimed at systematization and more concise presentation of data. Major revision
Reviewer 2: I enjoyed reading this review and found many useful features. I particularly appreciated its attempt to engage with underlying theory regarding disease trajectories.
Overall the review is sound and has the potential to make an important contribution to understanding. Unfortunately there are some elementary miscarriages in its execution that would need addressing before publication. Some of the minor issues are listed in more detail below but for ease of identification here are my major concerns:
1. The authors confuse Reporting Standards with Standards of Conduct. Following good reporting standards does not ensure a good review and so it would be good to only cite reporting standards to affirm what they are intended for.
2. Certain points betray gravitation towards a quantitative paradigm e.g. discussion of "risk of bias", "blinding to authors", numbers of participants supporting a finding and numbers of studies required in a qualitative synthesis. Particularly missing (to address some of these) is a "reflexive statement" see example below given from this same target journal. This will also address potential influence of the charity as funder (see below)..
3. The authors present a "bricolage" of findings in the Results. Not only does it engage with the conventions of quantitative research (e.g. "most" participants and "many" participants) but it attributes specific individual statements to groups of individuals misrepresenting an individually worded comment as if an agreed common experience. The whole Results section needs rewriting framing findings as overall statements followed by illustrative verbatim extracts (judiciously selected). In practical terms the authors should look at each verbatim extract and ask: does this capture a common experience? can I frame these related extracts in my own words as generalities, or is this a unique insight? does this wording express the experience better than I can myself? At the moment these results are knitted togeher from the reviewers, the source authors and the verbatim extracts of participants.
4. Although studies are not excluded on the basis of quality it would be useful to at least comment on CASP questions that the collective set of five studies performed less well against (typically reflexivity performs less well).
Specific comments:
“Due to the rarity of this condition there is limited evidence exploring the experiences of individuals who have had GBS.” This sentence perpetrates a common fallacy i.e. that the prevalence of research is linked to prevalence of a condition. In many cases the reverse is true (and this has been particularly recorded for neurological disorders) ie. That rare conditions are more attractive to research than common ones. This is partly attributable to the fact that journals are part scientific documentation and part journalism, partly to the “politics” of research funding and partly to other factors.
“CIDP” – this appears in the Review question without being written in full. The review question should have both conditions in full with respective abbreviations in brackets. (Otherwise CIDP is used twice BEFORE being written in full). It is not appropriate to use unexplained abbreviations in the review question.
“January 2000 and November 2018, to ensure relevance to the present day,” This reads as a weak justification for date limit (cynically, I would say that you have probably selected an easily memorable but topically meaningless start date!).
“Joanna Briggs Institute” – It is unclear what this Data Source is.
“The search terms were entered in all possible combinations using Boolean operators and truncation, wherever deemed necessary” Not true! They would have been kept in sets of related concepts i.e. the GBS concept, the qualitative research concept. Not ALL possible combinations. Search terms should also best be presented as two sets for greater clarity. E.g. “(i) Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), acute inflammatory demyelinating polyneuropathy (AIDP) combined with (ii) qualitative research, interview, focus group, experiences, perceptions, attitudes, and views”.
“All studies were reviewed and screened by three reviewers” This is very unclear. Does this mean that “all references were reviewed and screened”. In a review “studies” don’t become “studies” until they are included. Before that they are first “references” and then “(full text) papers”
“Qualitative Checklist [15] was used to assess risk of bias in included studies of this review” – The CASP checklist is not validated for “risk of bias”. Indeed what “risk of bias” means in a qualitative sense is epistemologically unclear anyway. Describe it only as “quality assessment”.
“Quality, however, was not a criterion for exclusion of a study” This is a sound decision but requires a sentence or clause of explanation e.g. “given that the intent was interpretative….” Or something similar. Also, being accurate “quality” is not a criterion. “Poor quality” would be.
“Blinding to the names of the authors, journals, and results of each study was not possible,
since the same authors performed the screening and data extraction of the studies to be
included in the meta-synthesis.” You don’t typically see this spelled out, particularly as you don’t explain why this could be an issue. In my view this is a very quantitative way of handling a legitimate concern. In a QUALITATIVE synthesis like this I would expect instead a reflexivity statement that talks about all the authors positionality to the data.
See the following example from PLOS One:
“Reflexive statement. Reflexive accounting allows the reader of the final research product to assess the degree to which the prior views and experiences of the researcher may have influenced the design, data collection and data interpretation of the study or in this case, the synthesis of the findings of multiple studies. This review was conceived with an informed knowledge of caesarean section and a degree of professional distance, which arguably limited bias based on the team’s own experiences. APB is a medical officer with over 15 years of experience in maternal and perinatal health research and public health in general, and caesarean section in particular. CK, a medical sociologist, came to the project with prior beliefs about the complexity and interdependency of social factors driving caesarean section rates, principally informed Stakeholder views of interventions to reduce unnecessary caesareans targeted at organisations and systems by undertaking earlier primary research with women and health professionals in the UK. SD, a Professor of Midwifery, believed that maternity care organisations are complex adaptive systems, and that the organisational ethos can exert either toxic or enhancing effects that have real consequences for staff morale, engagement, attitudes, behaviours and performance”.
“Initially, participants from most included studies” Avoid this quantitative reporting , especially when you then attribute multiple studies to a single verbatim extract as in this example. This should be reported as:
“Participants variously described initial experiences associated with their first awareness of their condition: “strange or odd sensations or peculiar feelings”, such as tingling in their feet or having difficulty opening the lid of orange juice containers etc
Similarly with “Most participants, “tried to ignore the strangeness of their bodies” whereas”. Especially be aware that “most participants” or “many participants” from one study may not be “many” or “most” across the five studies. This is particularly important because an experience is not judged important or not simply on the basis of whether it is a common experience or unique to that individual.
“Given that not many (especially not qualitative) studies were found that incorporated the
experiences of GBS from onset of symptoms and onwards” – this sentence is difficult to interpret – by using words such as Qualitative/focus groups etcetera in your search strategy you were only looking for QUALITATIVE studies. The fact that you retrieved some that weren’t qualitative isn’t a valid basis for making pronouncements about the quantitative studies which would not be representative of the ones you did not retrieve. Focus only on what you were studying, not what you accidentally retrieved along the way.
“well established guidelines (ENTREQ), which limited the potential for bias” You make the mistake here (and above in Methods) of assuming that following ENTREQ REPORTING guidelines somehow has an impact on the quality of the CONDUCT of your review. What reporting guidelines do is make it easier for a Reader to detect threats to bias (however that can be defined within a qualitative paradigm); they don’t make your review better.
“A potential limitation of this review was only five studies met the inclusion criteria for meta
synthesis” – this is largely an irrelevancy – you should consider the adequacy of your data (cp GRADE CERQual on adequacy) which is a function of both numbers of studies and their richness. So reframe as adequacy – they could still be adequate even if not plentiful. If, however they are neither rich nor plentiful then you should specifically identify what data were missing.
Similarly the reason why there are no guidelines on how many studies should be included is that this is bringing in a quantitative criterion to a qualitative phenomenon. Why are MORE studies needed? Not because the numbers aren’t sufficient – if you are going to recommend more studies then you must state which perspectives or elements of the experience are missing and therefore need more data. Otherwise you are simply advocating wasted research monies!
“Including exclusively English-language papers could be considered a weakness, as
important evidence may have been excluded due to language restrictions” This is true but you might wish to rebut this by saying “However, methods for translating concepts across languages, in addition to the initial challenge of translating them across studies, have not been sufficiently developed”.
There are several mentions of the role of “charities” in the Discussion. Given the funding for this study it would be good for the Reflexivity statement (as recommended above) to specifically address this. E.g. “The authors consider provision of information and support from charities as an important resource for patients, particularly with rare conditions, but such support may be available from multiple sources, and our view on potential sources may have been influenced by the funding for this study”. Major revision
[Note: HTML markup is below. Please do not edit.]
Reviewers' comments:
Reviewer's Responses to Questions
1. Is the manuscript technically sound, and do the data support the conclusions?
The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.
Reviewer #1: Partly
Reviewer #2: Partly
**********
2. Has the statistical analysis been performed appropriately and rigorously?
Reviewer #1: Yes
Reviewer #2: N/A
**********
3. Have the authors made all data underlying the findings in their manuscript fully available?
The
Reviewer #1: Yes
Reviewer #2: Yes
**********
4. Is the manuscript presented in an intelligible fashion and written in standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
Reviewer #1: Yes
Reviewer #2: Yes
**********
5. Review Comments to the Author
Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)
Reviewer #1: I've read with great interested this work by Siriwardena et al. dedicated to patients’ perceptions of Guillain-Barré syndrome. Undoubtedly, the data presented in this article are of great interest for specialists working with such patients. However, in my opinion, this article is extremely overloaded with data, which makes it really huge and looks like small book or thesis but not journal article. For instance, discussion section essentially repeats, in an abbreviated version, most of the theses set out in the results.
The design of the study is not completely looks optimal to me, because it is not clear what new information this meta-synthesis provides us, compared to the five qualitative studies that were included in the analysis. What has changed in our understanding of the problem after this work? It is also not entirely clear why the authors excluded quantitative works, because, at least, discussion sections of them could also contain some useful information.
In my opinion, the work needs a serious revision aimed at systematization and more concise presentation of data.
Reviewer #2: I enjoyed reading this review and found many useful features. I particularly appreciated its attempt to engage with underlying theory regarding disease trajectories.
Overall the review is sound and has the potential to make an important contribution to understanding. Unfortunately there are some elementary miscarriages in its execution that would need addressing before publication. Some of the minor issues are listed in more detail below but for ease of identification here are my major concerns:
1. The authors confuse Reporting Standards with Standards of Conduct. Following good reporting standards does not ensure a good review and so it would be good to only cite reporting standards to affirm what they are intended for.
2. Certain points betray gravitation towards a quantitative paradigm e.g. discussion of "risk of bias", "blinding to authors", numbers of participants supporting a finding and numbers of studies required in a qualitative synthesis. Particularly missing (to address some of these) is a "reflexive statement" see example below given from this same target journal. This will also address potential influence of the charity as funder (see below)..
3. The authors present a "bricolage" of findings in the Results. Not only does it engage with the conventions of quantitative research (e.g. "most" participants and "many" participants) but it attributes specific individual statements to groups of individuals misrepresenting an individually worded comment as if an agreed common experience. The whole Results section needs rewriting framing findings as overall statements followed by illustrative verbatim extracts (judiciously selected). In practical terms the authors should look at each verbatim extract and ask: does this capture a common experience? can I frame these related extracts in my own words as generalities, or is this a unique insight? does this wording express the experience better than I can myself? At the moment these results are knitted togeher from the reviewers, the source authors and the verbatim extracts of participants.
4. Although studies are not excluded on the basis of quality it would be useful to at least comment on CASP questions that the collective set of five studies performed less well against (typically reflexivity performs less well).
Specific comments:
“Due to the rarity of this condition there is limited evidence exploring the experiences of individuals who have had GBS.” This sentence perpetrates a common fallacy i.e. that the prevalence of research is linked to prevalence of a condition. In many cases the reverse is true (and this has been particularly recorded for neurological disorders) ie. That rare conditions are more attractive to research than common ones. This is partly attributable to the fact that journals are part scientific documentation and part journalism, partly to the “politics” of research funding and partly to other factors.
“CIDP” – this appears in the Review question without being written in full. The review question should have both conditions in full with respective abbreviations in brackets. (Otherwise CIDP is used twice BEFORE being written in full). It is not appropriate to use unexplained abbreviations in the review question.
“January 2000 and November 2018, to ensure relevance to the present day,” This reads as a weak justification for date limit (cynically, I would say that you have probably selected an easily memorable but topically meaningless start date!).
“Joanna Briggs Institute” – It is unclear what this Data Source is.
“The search terms were entered in all possible combinations using Boolean operators and truncation, wherever deemed necessary” Not true! They would have been kept in sets of related concepts i.e. the GBS concept, the qualitative research concept. Not ALL possible combinations. Search terms should also best be presented as two sets for greater clarity. E.g. “(i) Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), acute inflammatory demyelinating polyneuropathy (AIDP) combined with (ii) qualitative research, interview, focus group, experiences, perceptions, attitudes, and views”.
“All studies were reviewed and screened by three reviewers” This is very unclear. Does this mean that “all references were reviewed and screened”. In a review “studies” don’t become “studies” until they are included. Before that they are first “references” and then “(full text) papers”
“Qualitative Checklist [15] was used to assess risk of bias in included studies of this review” – The CASP checklist is not validated for “risk of bias”. Indeed what “risk of bias” means in a qualitative sense is epistemologically unclear anyway. Describe it only as “quality assessment”.
“Quality, however, was not a criterion for exclusion of a study” This is a sound decision but requires a sentence or clause of explanation e.g. “given that the intent was interpretative….” Or something similar. Also, being accurate “quality” is not a criterion. “Poor quality” would be.
“Blinding to the names of the authors, journals, and results of each study was not possible,
since the same authors performed the screening and data extraction of the studies to be
included in the meta-synthesis.” You don’t typically see this spelled out, particularly as you don’t explain why this could be an issue. In my view this is a very quantitative way of handling a legitimate concern. In a QUALITATIVE synthesis like this I would expect instead a reflexivity statement that talks about all the authors positionality to the data.
See the following example from PLOS One:
“Reflexive statement. Reflexive accounting allows the reader of the final research product to assess the degree to which the prior views and experiences of the researcher may have influenced the design, data collection and data interpretation of the study or in this case, the synthesis of the findings of multiple studies. This review was conceived with an informed knowledge of caesarean section and a degree of professional distance, which arguably limited bias based on the team’s own experiences. APB is a medical officer with over 15 years of experience in maternal and perinatal health research and public health in general, and caesarean section in particular. CK, a medical sociologist, came to the project with prior beliefs about the complexity and interdependency of social factors driving caesarean section rates, principally informed Stakeholder views of interventions to reduce unnecessary caesareans targeted at organisations and systems by undertaking earlier primary research with women and health professionals in the UK. SD, a Professor of Midwifery, believed that maternity care organisations are complex adaptive systems, and that the organisational ethos can exert either toxic or enhancing effects that have real consequences for staff morale, engagement, attitudes, behaviours and performance”.
“Initially, participants from most included studies” Avoid this quantitative reporting , especially when you then attribute multiple studies to a single verbatim extract as in this example. This should be reported as:
“Participants variously described initial experiences associated with their first awareness of their condition: “strange or odd sensations or peculiar feelings”, such as tingling in their feet or having difficulty opening the lid of orange juice containers etc
Similarly with “Most participants, “tried to ignore the strangeness of their bodies” whereas”. Especially be aware that “most participants” or “many participants” from one study may not be “many” or “most” across the five studies. This is particularly important because an experience is not judged important or not simply on the basis of whether it is a common experience or unique to that individual.
“Given that not many (especially not qualitative) studies were found that incorporated the
experiences of GBS from onset of symptoms and onwards” – this sentence is difficult to interpret – by using words such as Qualitative/focus groups etcetera in your search strategy you were only looking for QUALITATIVE studies. The fact that you retrieved some that weren’t qualitative isn’t a valid basis for making pronouncements about the quantitative studies which would not be representative of the ones you did not retrieve. Focus only on what you were studying, not what you accidentally retrieved along the way.
“well established guidelines (ENTREQ), which limited the potential for bias” You make the mistake here (and above in Methods) of assuming that following ENTREQ REPORTING guidelines somehow has an impact on the quality of the CONDUCT of your review. What reporting guidelines do is make it easier for a Reader to detect threats to bias (however that can be defined within a qualitative paradigm); they don’t make your review better.
“A potential limitation of this review was only five studies met the inclusion criteria for meta
synthesis” – this is largely an irrelevancy – you should consider the adequacy of your data (cp GRADE CERQual on adequacy) which is a function of both numbers of studies and their richness. So reframe as adequacy – they could still be adequate even if not plentiful. If, however they are neither rich nor plentiful then you should specifically identify what data were missing.
Similarly the reason why there are no guidelines on how many studies should be included is that this is bringing in a quantitative criterion to a qualitative phenomenon. Why are MORE studies needed? Not because the numbers aren’t sufficient – if you are going to recommend more studies then you must state which perspectives or elements of the experience are missing and therefore need more data. Otherwise you are simply advocating wasted research monies!
“Including exclusively English-language papers could be considered a weakness, as
important evidence may have been excluded due to language restrictions” This is true but you might wish to rebut this by saying “However, methods for translating concepts across languages, in addition to the initial challenge of translating them across studies, have not been sufficiently developed”.
There are several mentions of the role of “charities” in the Discussion. Given the funding for this study it would be good for the Reflexivity statement (as recommended above) to specifically address this. E.g. “The authors consider provision of information and support from charities as an important resource for patients, particularly with rare conditions, but such support may be available from multiple sources, and our view on potential sources may have been influenced by the funding for this study”.
**********
6. PLOS authors have the option to publish the peer review history of their article (
If you choose “no”, your identity will remain anonymous but your review may still be made public.
Reviewer #1: No
Reviewer #2: Yes: Andrew Booth
[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]
While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,
See uploaded file: Response to reviewers
Submitted filename:
PONE-D-19-33700R1
Patients’ experiences and perceptions of Guillain-Barré syndrome: a systematic review and meta-synthesis of qualitative research
PLOS ONE
Dear Dr. Siriwardena,
Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we invite you to undertake some minor revision and submit a revised version of the manuscript that addresses the points raised during the review process.
Please submit your revised manuscript by Jan 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at
Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see:
We look forward to receiving your revised manuscript.
Kind regards,
Kathleen Finlayson
Academic Editor
PLOS ONE
Additional Editor Comments (if provided):
Thank you for addressing the reviewers' comments, the review is well written and addresses a significant area of research. Please note the recommendation below to further condense the article. I would recommend this for the introduction, and adding in the recommendations for policy and practice within the discussion.
[Note: HTML markup is below. Please do not edit.]
Reviewers' comments:
Reviewer's Responses to Questions
1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.
Reviewer #1: (No Response)
**********
2. Is the manuscript technically sound, and do the data support the conclusions?
The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.
Reviewer #1: Partly
**********
3. Has the statistical analysis been performed appropriately and rigorously?
Reviewer #1: N/A
**********
4. Have the authors made all data underlying the findings in their manuscript fully available?
The
Reviewer #1: Yes
**********
5. Is the manuscript presented in an intelligible fashion and written in standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
Reviewer #1: Yes
**********
6. Review Comments to the Author
Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)
Reviewer #1: I thank authors for their efforts to improve the paper but from my point of view manuscript is still too long for publication as a journal article, especially it important for intro and results sections.
**********
7. PLOS authors have the option to publish the peer review history of their article (
If you choose “no”, your identity will remain anonymous but your review may still be made public.
Reviewer #1: No
[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]
While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,
Dear Dr Bilotta,
Article title: Patients’ experiences and perceptions of Guillain-Barré syndrome: a systematic review and meta-synthesis of qualitative research
Thank you for your further feedback on the paper and advice from editors and reviewers on minor revision of the paper following our previous major revision.
We have substantially shorted the introduction and results and adjusted the discussion in line with the advice given. Details of our response are below.
Thank you for reconsidering the revised paper for publication.
Yours sincerely,
Prof A. N. Siriwardena on behalf of the authors
Editor/reviewer comments Response
Additional Editor Comments (if provided): Thank you for addressing the reviewers' comments the review is well written and addresses a significant area of research. Please note the recommendation below to further condense the article. I would recommend this for the introduction and adding in the recommendations for policy and practice within the discussion. Thank you. We have condensed the text considerably and added recommendations for policy and practice in the discussion.
Reviewer #1: I thank authors for their efforts to improve the paper but from my point of view manuscript is still too long for publication as a journal article especially it important for intro and results sections.
Thank you. We have shortened the article as far as possible without changing the meaning of the text. The Background has been reduced from 1042 to 893 words and the Results from 2528 to 2103 words. The other sections
Submitted filename:
Patients’ experiences and perceptions of Guillain-Barré syndrome: a systematic review and meta-synthesis of qualitative research
PONE-D-19-33700R2
Dear Dr. Siriwardena,
We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at
If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact
Kind regards,
Kathleen Finlayson
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
Thank you for your response to the reviewers' suggestions. The manuscript is more succinct and provides a valuable contribution to understanding of this area.
Reviewers' comments:
PONE-D-19-33700R2
Patients’ experiences and perceptions of Guillain-Barré syndrome: a systematic review and meta-synthesis of qualitative research
Dear Dr. Siriwardena:
I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.
If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact
If we can help with anything else, please email us at
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Kathleen Finlayson
Academic Editor
PLOS ONE